References | |
---|---|
Percentage of patients with HbA1c < 7% | [83] |
Time required to reach targets of HbA1c, sBP and LDL cholesterol | [87] |
Comparison between personalized HbA1c target and actual HbA1c levels | [73] |
Percentage of patients who do not achieve the individualized targets | [90] |
Life expectancy and economic burden associated with diabetes-related complications in populations reaching different targets of HbA1c, in a series of models of delayed therapy intensification e and across a range of time horizons | [91] |
Median time to the progression of diabetic retinopathy | [92] |
Incidence rate of diabetic retinopathy progression in presence or absence of clinical inertia (lack of initiation of insulin therapy within 3 months from a report of HBA1c > 9%) | [92] |